drmelcalvert Profile Banner
Mel Calvert Profile
Mel Calvert

@drmelcalvert

Followers
1K
Following
5K
Media
122
Statuses
1K

Professor Outcomes Methodology, Director @CPROR_UoB & BHP Centre Regulatory Science & Innovation #NIHR Senior Investigator Passionate #PROs #CRSI #spiritAI #PPI

Joined August 2013
Don't wanna be here? Send us removal request.
@drmelcalvert
Mel Calvert
6 months
RT @BirminghamBRC: 📢 A new network will foster collaboration among regulators, industry & researchers to identify regulatory strategies tha….
0
3
0
@drmelcalvert
Mel Calvert
1 year
RT @NatureMedicine: Patient-reported outcomes are invaluable tools, but may impose a burden on patients; Olalekan Lee Aiyegbusi and colleag….
0
7
0
@drmelcalvert
Mel Calvert
1 year
RT @christel_UoB: NEW PUBLICATION!!!! Our team at @CPROR_UoB along with other colleagues have produced a list of recommendations to address….
0
8
0
@drmelcalvert
Mel Calvert
2 years
0
1
0
@drmelcalvert
Mel Calvert
2 years
RT @ChristinaBYap: 6/ At the core of all our work is the aim to improve clinical trials for the benefit of patients. Thanks to our incredib….
0
2
0
@drmelcalvert
Mel Calvert
2 years
RT @ChristinaBYap: 1/ NEW early phase dose-finding reporting guidelines for trial protocols (SPIRIT-DEFINE) and trial reports (CONSORT-DEFI….
Tweet card summary image
bmj.com
The CONSORT (CONsolidated Standards Of Reporting Trials) 2010 statement is the standard guideline for reporting completed randomised trials. The CONSORT Dose-finding Extension (DEFINE) extends the...
0
26
0
@drmelcalvert
Mel Calvert
2 years
RT @samsamcr: Delighted to share that our systematic review on the effects of disease modifying therapies in multiple sclerosis has been pu….
0
1
0
@drmelcalvert
Mel Calvert
2 years
RT @tlcstudy: Our patient partners are so talented!.A little overwhelmed when we received this poem from one of our patient partners. #Pa….
0
3
0
@drmelcalvert
Mel Calvert
2 years
RT @christel_UoB: ***NEW PUBLICATION*** Development and testing of an #ePRO solution for patients with inflammatory diseases in an early ph….
0
2
0
@drmelcalvert
Mel Calvert
2 years
RT @christel_UoB: NEW PUBLICATION! @KonradMaruszczy reports results from #qualitative itvs with stakeholders on #PROs providing evidence of….
0
3
0
@drmelcalvert
Mel Calvert
2 years
RT @christel_UoB: Our @tlcstudy latest paper on Patient & Public Involvement in Health Research has just been published! Huge thanks to our….
0
13
0
@drmelcalvert
Mel Calvert
2 years
RT @UoB_IAHR: Superb networking and exchanging thoughts and new ideas at our @UoB_IAHR Away Day with @KKCheng4 and @terobertsbham #weareIA….
0
10
0
@drmelcalvert
Mel Calvert
2 years
RT @BirminghamBRC: Are you passionate about promoting equality, diversity and inclusion (#EDI) in research and searching for a new opportun….
0
10
0
@drmelcalvert
Mel Calvert
2 years
RT @pkluetz: Please join if you can. Patient generated data to inform the tolerability of drug products… exploring single item overall side….
0
2
0
@drmelcalvert
Mel Calvert
2 years
Lovely day in Sheffield at #UKPROMS many thanks to the organisers @jillcarton1 @ScHARRSheffield
Tweet media one
2
2
32
@drmelcalvert
Mel Calvert
2 years
RT @InflamAge_UoB: 🎉Congratulations to Prof @Denniston_Ophth on receipt of his prestigious @NIHRresearch Incubator award! 🙌.Prof Denniston….
0
23
0
@drmelcalvert
Mel Calvert
2 years
RT @christel_UoB: *** New publication*** Usability of #ePRO platform with #cancer sufferers➡️huge potential for communicating with clinicia….
0
2
0
@drmelcalvert
Mel Calvert
2 years
RT @FDAOncology: Register and join us June 27 at 11am ET. FDA 8th Annual COA-CCT Workshop. #OCEOutcomes23. https://….
0
5
0